Benitec Biopharma Inc. (BNTC) vs CapsoVision, Inc. (CV)
A side-by-side comparison of Benitec Biopharma Inc. and CapsoVision, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNTC
Benitec Biopharma Inc.
$8.87HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
CV
CapsoVision, Inc.
$6.47HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
Total return — BNTC vs CV
growth of $100 · dividends reinvested · last 1yBNTC -27.6% (-27.6%/yr)CV +88.3% (+88.3%/yr)CV compounded faster over this window
BNTC CV
BNTC vs CV: by the numbers
- •CV is the larger company ($323M vs $305M market cap).
- •Both run net losses; BNTC's is the smaller (0.00% vs -214.74% net margin).
Metrics side by side
Valuation
| Metric | BNTC | CV |
|---|---|---|
| P/S ratio | N/A | 23.25 |
| P/B ratio | 1.72 | 24.53 |
Profitability
| Metric | BNTC | CV |
|---|---|---|
| Gross margin | 0.00% | 50.88% |
| Operating margin | 0.00% | -188.25% |
| Net margin | 0.00% | -214.74% |
| ROE | -25.73% | -226.56% |
| ROIC | -28.88% | -164.32% |
Growth (annualized)
| Metric | BNTC | CV |
|---|---|---|
| Total return CAGR (5Y) | -31.08% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.